Screener
Krystal Biotech, Inc. KRYS Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $7.55B.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
FAQ
- What is Krystal Biotech, Inc.'s market capitalization?
- Krystal Biotech, Inc. (KRYS) reported market capitalization of $7.55B in Q1 2026.
- How has Krystal Biotech, Inc.'s market capitalization changed year-over-year?
- Krystal Biotech, Inc.'s market capitalization increased by 45.4% year-over-year, from $5.19B to $7.55B.
- What is the long-term trend for Krystal Biotech, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s market capitalization has grown at a 36.8% compound annual growth rate (CAGR), from $1.49B to $7.15B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Krystal Biotech, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude